DataMeds AI (MEDS) EBT (2024 - 2026)

DataMeds AI (MEDS) has reported EBT for 3 consecutive years, with -$7.7 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 76.13% year-over-year to -$7.7 million; the trailing twelve-month figure through Mar 2026 stood at -$76.6 million (down 95.35% YoY), and the FY2025 full-year result was -$101.3 million, down 1377.12% from the prior year.
• EBT climbed to -$7.7 million in Q1 2026 per MEDS's latest filing, from -$27.9 million in the prior quarter.
• Across five years, EBT topped out at -$83122.0 in Q1 2024 and bottomed at -$34.3 million in Q3 2025.
• Historically, EBT has averaged -$12.9 million across 3 years, with a median of -$6.7 million in 2025.
• The sharpest annual moves came in 2025 and 2026: EBT slumped 38916.03% in 2025, then soared 76.13% in 2026.
• Over 3 years, EBT stood at -$4.3 million in 2024, then slumped by 543.0% to -$27.9 million in 2025, then surged by 72.2% to -$7.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$7.7 million, -$27.9 million, and -$34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.